½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1444420

¼¼°èÀÇ ÀǾàÇ°¿ë Çöó½ºÆ½º´ ½ÃÀå : Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)

Pharmaceutical Plastic Bottles - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Mordor Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀǾàÇ°¿ë Çöó½ºÆ½º´(Pharmaceutical Plastic Bottles) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 92¾ï 2,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2029³â±îÁö 112¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, ¿¹Ãø ±â°£(2024-2029³â) Áß¿¡ 4.07%ÀÇ CAGRÀ» ±â·Ï ÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÀǾàÇ°¿ë Çöó½ºÆ½º´-½ÃÀå

ÀǾàÇ° º¸°ü ¹× ¹è¼ÛÀ» À§ÇÑ ÀǾàÇ° Æ÷Àå¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

  • Çöó½ºÆ½ Æ÷Àå ¼ö¿ä´Â Ź¿ùÇÑ ´É·ÂÀ¸·Î Á¦¾à ¾÷°è¿¡¼­ Å©°Ô ¼ºÀåÇÏ°í ÀÖ½À´Ï´Ù. Á¦¾à ºÐ¾ß¿¡¼­ äÅà Áõ°¡·Î À̾îÁø Ãß°¡ ±â´ÉÀº ½À±â¿¡ ´ëÇÑ À庮, ³ôÀº Ä¡¼ö ¾ÈÁ¤¼º, ³ôÀº Ãæ°Ý °­µµ, ¿Ö°î¿¡ ´ëÇÑ ³»¼º, ÀúÈí¼ö¼º, Åõ¸í¼º, ³»¿­¼º¡¤³»È­¼º ¹× À¯È¿±â°£ÀÇ ¿¬Àå µîÀÌ ÀÖ½À´Ï´Ù.
  • Á¦¾à¾÷°èÀÇ ÀçÈ°¿ë·ü Çâ»ó°ú ȯ°æ¿µÇâ ÃÖ¼ÒÈ­·Î Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁü¿¡ µû¶ó ÀǾàÇ°¿ë Çöó½ºÆ½º´ ½ÃÀåÀÌ ¼ºÀåÇÏ°í ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀü°ú °íü ¹× ¾×ü °æ±¸ ¾à¹°¿¡¼­ Çöó½ºÆ½º´ÀÇ ÀÀ¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀǾàÇ°¿ë Çöó½ºÆ½º´ ½ÃÀå ¼ºÀåÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¿øÀ¯°¡°Ý º¯µ¿°ú °¢Á¾ ±ÔÁ¦¿¡ µû¸¥ Çöó½ºÆ½ °¡°Ý »ó½ÂÀº Çöó½ºÆ½ °¡°Ý »ó½ÂÀ» ¹Ý¿µÇÏ¿© Á¦Ç° ¼Òºñ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í Á¶»ç ´ë»ó ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ¾÷°è¿¡¼­´Â ¹«±Õ ÃæÀü ¹× Æ÷Àå¿¡ Çöó½ºÆ½º´ÀÌ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå °ø±Þ¾÷ü´Â ´Ù¾çÇÑ Áö¿ª¿¡¼­ ¹«±Õ º´ ÃæÀü ¹× Æ÷Àå ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, LSNE´Â ¹«±Õ ½ºÆ÷ÀÌµå º´ ÃæÀü ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ È¸»ç´Â Ç¥ÁØ ´ÙÁß ¿ë·®ÀÇ 3°³ º´À» 5ml¿Í 10ml º´, ±×¸®°í ¸ê±Õ ´ÙÁß ¿ë·® º´¿¡ ä¿ï ¼öÀÖ´Â ÀÚµ¿ ÃæÀü ¶óÀÎÀ» °®Ãß°í ÀÖ½À´Ï´Ù.
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç¿¡´Â PET ¼öÁö¿Í Æú¸®¸Ó »ý»ê ±âÁö°¡ ÀÖÀ¸¸ç ¿øÀç·á °ø±Þ ºÎÁ· ¹®Á¦ ¾øÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í ÀÖ½À´Ï´Ù. Áß±¹Àº PET º´ÀÇ °¡Àå Å« »ý»ê±¹ÀÌ¸ç ¼Òºñ±¹ Áß ÇϳªÀÔ´Ï´Ù.
  • ÀǾàÇ° ¹× ±âŸ ÇʼöÇ°¿¡ ´ëÇÑ ¼ö¿ä°¡ °ú°Å ¾øÀ» Á¤µµ·Î ³ô¾ÆÁü¿¡ µû¶ó Æ÷Àå ¹× ÃâÇϸ¦ À§ÇÑ Æ÷ÀåÀç°¡ ºÎÁ·ÇÏ¿© °ø±Þ¸Á¿¡ »ó´çÇÑ Áß´ÜÀÌ ¹ß»ýÇß½À´Ï´Ù. ±×·¯³ª COVID-19 ȯÀÚ¿¡°Ô »ç¿ëµÇ´Â ÀϺΠÀǾàÇ°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù. ¿©±â¿¡´Â ¿©·¯ ¸¶ÃëÁ¦, Ç×»ýÁ¦, ±ÙÀ° ÀÌ¿ÏÁ¦ ¹× ÀϺΠÀûÀÀ ¿Ü¾àÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ°ÍÀº Á¦¾à ȸ»ç¿¡ Çöó½ºÆ½º´ °ø±ÞÀ¸·Î À̾îÁ³½À´Ï´Ù.

ÀǾàÇ°¿ë Çöó½ºÆ½º´ ½ÃÀå µ¿Çâ

HDPE ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» ±â·Ï

  • HDPE´Â ´Ù¾çÇÑ º´ÀÇ Á¦Á¶¿¡ »ç¿ëµÇ°í ÀÖÀ¸¸ç, ±× Áß¿¡¼­µµ ¹«Âø»öÀÇ º´Àº ¹ÝÅõ¸íÇÏ°í °­¼º°ú ¹è¸®¾î¼ºÀÌ ¿ì¼öÇÕ´Ï´Ù. ÀÌ Àç·á´Â Âø»öµÈ ´Ù¾çÇÑ À¯Çü°¡ ÀÖÀ¸¸ç Á¦¾à ¾÷°è¿¡¼­ °¨±¤¼º ¾à¹°À» Æ÷ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Àç·á´Â º¸Á¸ °¡´É ±â°£ÀÌ ÂªÀº Á¦Ç°ÀÇ Æ÷Àå¿¡ ÀûÇÕÇÕ´Ï´Ù. ¹Ì±¹ È­ÇÐÇùȸ¿¡ µû¸£¸é 2021³â ¹Ì±¹Àº 1,239¾ï ÆÄ¿îµåÀÇ ¼öÁö¸¦ »ý»êÇßÀ¸¸ç, ±× Áß ¿­°¡¼Ò¼º Çöó½ºÆ½Àº ÃÑ »ý»ê·®ÀÇ ¾à 86%¸¦ Â÷ÁöÇß½À´Ï´Ù. °í¹Ðµµ Æú¸®¿¡Æ¿·»(HDPE)Àº ±× ÇØ¿¡ °¡Àå ¸¹ÀÌ »ý»êµÈ ¼öÁö·Î »ý»ê·®Àº 220¾ï ÆÄ¿îµå¿´½À´Ï´Ù.
  • HDPE´Â ³»È­ÇмºÀÌ ¿ì¼öÇϱ⠶§¹®¿¡ ´Ù¾çÇÑ È­ÇÐÁ¦Ç° ¹× ÀǾàÇ° Æ÷Àå¿¡ ±ÍÁßÇÑ Àç·á·Î »ç¿ëµË´Ï´Ù. Âø»öµÈ HDPE º´Àº Âø»öµÇÁö ¾ÊÀº HDPE Àç·áº¸´Ù ½ºÆ®·¹½º ±Õ¿­ ÀúÇ×¼ºÀÌ Çâ»óµÇ´Â °ÍÀ¸·Î È®ÀεǾú½À´Ï´Ù. HDPE´Â ºí·Î¿ì ¼ºÇüÀ¸·Î PP ¹× LDPE Àç·áº¸´Ù ³»±¸¼ºÀÌ ¶Ù¾î³ª ¹ü¿ë¼ºÀÌ ³ô¾ÆÁý´Ï´Ù. ¶ÇÇÑ ´Ù¸¥ ÇüÅÂÀÇ Æú¸®¿¡Æ¿·» Àç·á¿Í ºñ±³ÇÏ¿© ´ëºÎºÐÀÇ ¿ë¸Å¿¡ ´ëÇÑ ¿ì¼öÇÑ ³»¼º°ú ³ôÀº ÀÎÀå °­µµ¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.
  • HDPE´Â ÀϹÝÀûÀÎ Æú¸®¸Ó Áß ³ôÀº °­µµ ´ë Áß·®ºñ¸¦ °¡Áö¸ç PPº¸´Ù Ãë¾àÇÏÁö ¾Ê±â ¶§¹®¿¡ ÁÖ·Î »ó¾÷ ºÎ¹®ÀÇ ´ëÇü ¿ë±â¿¡µµ »ç¿ëµË´Ï´Ù. ¼ºÇü½Ã °æ·®ÀÇ ¼ºÁúÀ» À¯ÁöÇÒ ¼ö Àֱ⠶§¹®¿¡ Çöó½ºÆ½ ij´Ï½ºÅÍ µî Å« ¿ë±â¿¡ ÀûÇÕÇÕ´Ï´Ù.
  • °Ô´Ù°¡, ½ÃÀå¿¡¼­´Â ¿©·¯ ±â¾÷¿¡ ÀÇÇÑ ´Ù¾çÇÑ ¿¬±¸°³¹ß È°µ¿ÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 4¿ù Advil Á¦Á¶¾÷üÀÎ GSK Consumer Healthcare(GSK)´Â 8,000¸¸°³°¡ ³Ñ´Â Advil º´ÀÇ Çöó½ºÆ½À» 20% ÁÙÀ̱â À§ÇÑ ³ë·ÂÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ·Î ÀÎÇØ È¯°æÀÇ Çöó½ºÆ½ÀÌ 50¸¸ ÆÄ¿îµå °¡±îÀÌ ÁÙ¾îµì´Ï´Ù. AdvilÀº 2022³â±îÁö ÀÌ ºê·£µåÀÇ ÀÌÁö ¿ÀÇ º´À» Á¦¿ÜÇÑ »óÁ¡°ú ¿Â¶óÀο¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â °ÅÀÇ ¸ðµç º´¿¡¼­ Çöó½ºÆ½À» ÁÙÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. »õ·Î¿î À庮 ¼öÁö ±â¼úÀº À庮 º¸È£ Ư¼ºÀ» À¯ÁöÇϸ鼭 °í¹Ðµµ Æú¸®¿¡Æ¿·»(HDPE) º´ÀÇ ¼ºÇü ¹× Á¦Á¶¿¡ ÇÊ¿äÇÑ ¼öÁöÀÇ ¾çÀ» ÁÙÀÔ´Ï´Ù.

ºÏ¹Ì°¡ Å« ½ÃÀå Á¡À¯À²À» Â÷Áö

  • ¹Ì±¹ÀÇ Çöó½ºÆ½º´ ½ÃÀåÀº Çöó½ºÆ½ ¿ë±â¿Í º´ÀÇ ¼Òºñ¿Í »ê¾÷¿ëµµ°¡ ²÷ÀÓ¾øÀÌ Áõ°¡ÇÏ°í Àֱ⠶§¹®¿¡ ¾ÈÁ¤µÈ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. Çöó½ºÆ½ »ê¾÷ Çùȸ(PLASTICS)¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â Çöó½ºÆ½º´ ½ÃÀå ¼ö¿ä°¡ °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù.
  • Pharmaceutical Commerce¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ÀǾàÇ° ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. 2023³â±îÁö ¹Ì±¹ÀεéÀº ÀǾàÇ°¿¡ 6,350¾ï ´Þ·¯¿¡¼­ 6,550¾ï ´Þ·¯¸¦ ÁöÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× °á°ú ¹Ì±¹Àº °¡Àå ÀǾàÇ° ÁöÃâÀÌ ¸¹Àº ³ª¶ó°¡ µË´Ï´Ù.
  • ¶ÇÇÑ Pharmaceutical Commerce¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ÀǾàÇ° ½ÃÀåÀÌ È®´ë °æÇâÀÌ ÀÖ½À´Ï´Ù. 2023³â±îÁö ¹Ì±¹ÀεéÀº ÀǾàÇ°¿¡ 6,350¾ï ´Þ·¯¿¡¼­ 6,550¾ï ´Þ·¯¸¦ ÁöÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× °á°ú, µ¿±¹ÀÌ °¡Àå ¸¹Àº ÀǾàÇ° ÁöÃâÀ» ½Ç½ÃÇÏ´Â ³ª¶ó°¡ µÇ´Â °ÍÀº °ÅÀÇ È®½ÇÇÕ´Ï´Ù.
  • Çöó½ºÆ½ ¼öÁö ¹× Á¦Ç° ºÎ¹®¿¡¼­´Â 1,932°³ »ç¾÷Àå¿¡¼­ 93,000¸íÀÌ °í¿ëµÇ°í ÀÖ½À´Ï´Ù. Çöó½ºÆ½ Á¦Ç°Àº °ÅÀÇ ¸ðµç Çö´ë Á¦Ç°¿¡ »ç¿ëµÇ¸ç ij³ª´Ù¿¡¼­´Â ´ëºÎºÐÀÇ °æÁ¦ ºÐ¾ß¿¡¼­ ¼ö¿ä°¡ ÀÖÀ¸¸ç Æ÷Àå, °Ç¼³ ¹× ÀÚµ¿Â÷ÀÇ ¼¼ °¡Áö ¹üÁÖ°¡ Çöó½ºÆ½ ÃÖÁ¾ ¿ëµµÀÇ 69%¸¦ Â÷ÁöÇÕ´Ï´Ù.

ÀǾàÇ°¿ë Çöó½ºÆ½º´ »ê¾÷ °³¿ä

ÀǾàÇ° Çöó½ºÆ½º´ ½ÃÀåÀº Amcor Limited¿Í °°Àº ¸¹Àº ¼±¼öÀÇ Á¸Àç¿¡ ÀÇÇØ ¼¼ºÐÈ­µË´Ï´Ù. Berry Plastics Group, Inc., Aptar Pharma, Gerresheimer AG, Graham Packaging Company, Alpha Packaging ¹× Alpack Plastic Packaging°ú °°Àº ±â¾÷Àº ½ÃÀåÀ» µ¶Á¡Çϱâ À§ÇØ ÇÕº´ ¹× Àμö, ÆÄÆ®³Ê½Ê, ½ÅÁ¦Ç° Ãâ½Ã, Çù¾÷ µî ´Ù¾çÇÑ À¯±âÀûÀÌ°í ¹«±âÀûÀÎ Àü·«À» äÅÃÇÕ´Ï´Ù.

  • 2021³â 12¿ù : Comar´Â »çÃâ ¹× ºí·Î¿ì ¼ºÇü Á¦Ç° Á¦Á¶¾÷üÀÎ Omega PackagingÀ» ÀμöÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. Omega PackagingÀÇ ¾î¸°ÀÌ º¸È£(CR) ¸¶°³ ¶óÀΰú Á¤¹Ð ±ÝÇü Á¦ÀÛ ´É·ÂÀº ¿£µåÅõ¿£µå ¸ÂÃãÇü Á¦Á¶ ¿ª·®°ú È®ÀåµÈ Á¦Ç° Æ÷Æ®Æú¸®¿À·Î ÇコÄÉ¾î °í°´¿¡°Ô ¼­ºñ½º¸¦ Á¦°øÇÏ·Á´Â ComarÀÇ Àü·«À» ÇÑÃþ ´õ ¹ßÀü½Ãŵ´Ï´Ù.
  • 2021³â 9¿ù : Clearlake Capital GroupÀÇ Æ÷Æ®Æú¸®¿À ±â¾÷ÀÎ Pretium PackagingÀº ¹Ì±¹¿¡ º»»ç¸¦ µÐ Alpha PackagingÀ» Irving Place Capital¿¡¼­ ºñ°ø°³ ±Ý¾×À¸·Î ÀμöÇϱâ·Î ÇÕÀÇÇß½À´Ï´Ù. Alpha Packaging°ú Pretium PackagingÀ» ÅëÇØ ÅëÇÕ ±â¾÷Àº ¾ç»çÀÇ ±âÁ¸ °í°´ ±â¹Ý°ú ½Å±Ô °í°´¿¡°Ô ±¤¹üÀ§ÇÑ Ã·´Ü ÆÐŰ¡ ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

±âŸ ÇýÅÃ

  • ¿¢¼¿ Çü½Ä ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
  • 3°³¿ùÀÇ ¾Ö³Î¸®½ºÆ® ¼­Æ÷Æ®

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • Á¶»ç ÀüÁ¦ Á¶°Ç ¹× ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå °³¿ä
  • »ê¾÷ ¸Å·Âµµ-Porter's Five Forces ºÐ¼®
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ´ëü Á¦Ç°ÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • ¾÷°èÀÇ ¹ë·ùüÀÎ ºÐ¼®
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19 ¿µÇâ Æò°¡

Á¦5Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø ¿äÀÎ
    • ¼ÒºñÀÚ¿¡ ÀÇÇÑ °æ·® ÀǾàÇ° º´¿¡ ´ëÇÑ ´ÏÁî Áõ°¡
    • ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϱâ À§ÇØ ÇコÄÉ¾î ¹× ÀǾàÇ°¿¡ ´ëÇÑ ÁöÃâ Áõ´ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦ ¿äÀÎ
    • ¿øÀç·áºñ »ó½Â
    • Çöó½ºÆ½ »ç¿ë¿¡ °üÇÑ È¯°æ¿¡ ´ëÇÑ ¿ì·Á

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¿øÀç·áº°
    • Æú¸®¿¡Æ¿·»Å×·¹ÇÁÅ»·¹ÀÌÆ®(PET)
    • Æú¸®ÇÁ·ÎÇÊ·»(PP)
    • Àú¹Ðµµ Æú¸®¿¡Æ¿·»(LDPE)
    • °í¹Ðµµ Æú¸®¿¡Æ¿·»(HDPE)
  • À¯Çüº°
    • °íü ¿ë±â
    • ½ºÆ÷À̵庴
    • Á¡ºñ ½ºÇÁ·¹À̺´
    • ¾×üº´
    • ±¸°­ °ü¸®
    • ±âŸ À¯Çü
  • Áö¿ªº°
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
    • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ±âŸ À¯·´
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • ±âŸ ¾Æ½Ã¾Æ ÅÂÆò¾ç
    • ³²¹Ì
      • ºê¶óÁú
      • ¾Æ¸£ÇîƼ³ª
      • ¸ß½ÃÄÚ
      • ±âŸ ³²¹Ì
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦7Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Amcor Limited
    • Gerresheimer AG
    • Berry Group Inc.
    • Aptar Pharma
    • O.Berk Company LLC
    • Alpha Packaging
    • Pro-Pac Packaging Ltd
    • COMAR LLC
    • Gil Plastic Products Ltd
    • Drug Plastics Group
    • Frapak Packaging

Á¦8Àå ÅõÀÚ ºÐ¼®

Á¦9Àå ½ÃÀå ±âȸ ¹× ÇâÈÄ µ¿Çâ

LYJ 24.03.15

The Pharmaceutical Plastic Bottles Market size is estimated at USD 9.22 billion in 2024, and is expected to reach USD 11.26 billion by 2029, growing at a CAGR of 4.07% during the forecast period (2024-2029).

Pharmaceutical Plastic Bottles - Market

The growing demand for the packaging in pharmaceuticals for the storage and delivery of medicines is expected to drive the market during the forecast period.

Key Highlights

  • The demand for plastic packaging has witnessed significant growth in the pharmaceutical industry because of its unmatched ability. Additional features that led to increased adoption in pharma are barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, and extension of expiry dates.
  • The market for pharmaceutical plastic bottles is growing due to growing sustainability concerns by increasing the recycling rate and minimizing the environmental impact in the pharmaceutical industry. Technological advancement and the rising application of plastic bottles in solid and even liquid oral medicines have added to market growth for pharmaceutical plastic bottles. However, the rise in the price of plastics due to fluctuating prices of crude oil and various regulations would reflect on the increase in the price of plastics, which may affect the consumption of the product and further hinder the growth of the market studied.
  • Plastic bottles are increasingly used for aseptic filling and packaging in the industry. Market vendors provide aseptic bottle filling and packaging services in various regions. For instance, LSNE offers aseptic dropper bottle filling services. The company has an automated filling line capable of filling standard multi-dose three-piece bottles in 5 ml and 10 ml bottles and sterile multi-dose bottles.
  • Asia-Pacific has a prominent base for the production of PET resin and polymers, which is also aiding the growth of the market with no issues of a supply shortage of raw material. China is one of the largest producing and consuming countries of PET bottles.
  • With the increasing demand for medicine and other essential goods at an all-time high, a lack of available packaging to package and ship them further caused a significant interruption in supply chains. However, the demand increased for some medicines used in patients with COVID-19. These included some anesthetics, antibiotics, muscle relaxants, and some off-label medicines. This led to the supply of plastic bottles in the pharmaceutical companies.

Pharmaceutical Plastic Bottles Market Trends

HDPE Segment to Report the Highest Growth Rate

  • HDPE is used to manufacture various types of bottles, and among those, un-pigmented bottles are translucent, with excellent stiffness and barrier properties. The material has a pigmented variety, which can package light-sensitive drugs in the pharmaceutical industry. These materials are suited for packaging products with a short shelf life. According to American Chemical Council, in 2021, the United States produced 123.9 billion pounds of resins, in which thermoplastics accounted for roughly 86% of total production. High-density polyethylene (HDPE) was the most produced resin that year, with an output of 22 billion pounds.
  • HDPE also has excellent chemical resistance, which presents it as a valuable material for packaging various chemicals and medicinal products. Pigmented HDPE bottles are witnessed to have improved stress crack resistance than un-pigmented HDPE material. The blow-molding application of HDPE makes it more durable and more versatile than PP and LDPE materials. It also has excellent resistance to most solvents and high tensile strength compared to other forms of polyethylene materials.
  • HDPE is also primarily used for larger containers in the commercial sector as it has a high strength-to-weight ratio in common polymers and is less brittle than PP. It maintains a lightweight nature in molding, making it suitable for larger containers, like plastic canisters.
  • Further, there have been various research and development activities by multiple players in the market. For instance, in April 2021, Advil maker GSK Consumer Healthcare (GSK) announced a commitment to reducing the plastic in more than 80 million Advil bottles by 20%, which will result in a reduction of nearly 500,000 pounds of plastic in the environment. By 2022, Advil is expected to reduce plastic in nearly all bottles available in stores and online, except the brand's Easy Open bottles. The new barrier resin technology reduces the amount of resin required to mold and craft the high-density polyethylene (HDPE) bottles while maintaining barrier protection properties.

North America Accounts for a Significant Market Share

  • The US plastic bottles market is estimated to grow at a steady rate, owing to the constantly increasing consumption and industrial applications of plastic-made containers and bottles. According to the Plastics Industry Association (PLASTICS), the market demand for plastic bottles continues to expand in the United States.
  • According to Pharmaceutical Commerce, in the United States, the pharmaceutical market is on the rise. By 2023, it is expected that Americans would spend USD 635 to USD 655 billion on pharmaceuticals. As a result, the United States will be the country with the greatest pharmaceutical spending.
  • Moreover, according to Pharmaceutical Commerce, in the United States, the pharmaceutical market is on the rise. By 2023, it is expected that Americans will spend USD 635 to USD 655 billion on pharmaceuticals. As a result, it will almost certainly be the country with the most significant pharmaceutical spending.
  • The plastic resin and products sector employs 93,000 people across 1,932 establishments. With usage in almost every modern product, plastic products are in demand in Canada in most sectors of the economy, with three categories packaging, construction, and automotive accounting for 69% of plastic end use.

Pharmaceutical Plastic Bottles Industry Overview

The pharmaceutical plastic bottle market is fragmented with the presence of many players like Amcor Limited. Berry Plastics Group, Inc., Aptar Pharma, Gerresheimer AG, Graham Packaging Company, Alpha Packaging, and Alpack Plastic Packaging. The players have adopted various organic and inorganic strategies such as mergers & acquisitions, partnerships, new product launches, and collaborations to dominate the market.

  • December 2021 - Comar announced that it acquired Omega Packaging, an injection, and blow-molded product manufacturer. Omega Packaging's line of child-resistant (CR) closures and precision mold-building capabilities advance Comar's strategy to serve healthcare customers with end-to-end custom manufacturing capabilities and an expanded product portfolio.
  • September 2021 - Clearlake Capital Group portfolio company Pretium Packaging agreed to acquire US-based Alpha Packaging from Irving Place Capital for an undisclosed sum. Alpha Packaging and Pretium Packaging will allow the combined entity to offer a wide range of advanced packaging solutions to both firms' existing customer bases and new customers.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyer
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Growing Need for Lightweight Pharma Bottles by Consumers
    • 5.1.2 Increasing Spending on Healthcare and Pharmaceutical to Augment the Market Growth
  • 5.2 Market Restraints
    • 5.2.1 Increasing Raw Material Costs
    • 5.2.2 Environmental Concerns over Usage of Plastics

6 MARKET SEGMENTATION

  • 6.1 By Raw Material
    • 6.1.1 Polyethylene Terephthalate (PET)
    • 6.1.2 Poly Propylene (PP)
    • 6.1.3 Low-density Poly Ethylene (LDPE)
    • 6.1.4 High-density Poly Ethylene (HDPE)
  • 6.2 By Type
    • 6.2.1 Solid Containers
    • 6.2.2 Dropper Bottles
    • 6.2.3 Nasal Spray Bottles
    • 6.2.4 Liquid Bottles
    • 6.2.5 Oral Care
    • 6.2.6 Other Types
  • 6.3 By Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 United Kingdom
      • 6.3.2.2 Germany
      • 6.3.2.3 France
      • 6.3.2.4 Rest of Europe
    • 6.3.3 Asia-Pacific
      • 6.3.3.1 China
      • 6.3.3.2 India
      • 6.3.3.3 Japan
      • 6.3.3.4 Rest of Asia-Pacific
    • 6.3.4 Latin America
      • 6.3.4.1 Brazil
      • 6.3.4.2 Argentina
      • 6.3.4.3 Mexico
      • 6.3.4.4 Rest of Latin America
    • 6.3.5 Middle East & Africa
      • 6.3.5.1 Saudi Arabia
      • 6.3.5.2 United Arab Emirates
      • 6.3.5.3 South Africa
      • 6.3.5.4 Rest of Middle East & Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles*
    • 7.1.1 Amcor Limited
    • 7.1.2 Gerresheimer AG
    • 7.1.3 Berry Group Inc.
    • 7.1.4 Aptar Pharma
    • 7.1.5 O.Berk Company LLC
    • 7.1.6 Alpha Packaging
    • 7.1.7 Pro-Pac Packaging Ltd
    • 7.1.8 COMAR LLC
    • 7.1.9 Gil Plastic Products Ltd
    • 7.1.10 Drug Plastics Group
    • 7.1.11 Frapak Packaging

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦